Michelle Doig is a Partner and Head of Corporate Development at Omega Funds where she invests from Early Stage through Late Stage Venture across Biotechnology, Therapeutics, Oncology, and broader Life Sciences. She invests across North America and Western Europe, including the United States and United Kingdom. She serves on the boards of BridgeBio Oncology Therapeutics and Artios Pharma Ltd, is a board observer at Arrakis Therapeutics, and has invested in companies like Arrakis Therapeutics, Artios Pharma Ltd, Nuvation Bio, and Bicara Therapeutics. Before Omega Funds, she was Director, Corporate Finance at Third Rock Ventures, Principal, Corporate Finance at Abingworth, and an Associate at Lehman Brothers. She has also served as President and Director of Omega Alpha SPAC. Michelle studied at the Ivey Business School at Western University and lives in Toronto.
Michelle Doig, Partner @ Omega. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Michelle Doig from BBOT. Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Michelle
Map your path to Michelle instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Michelle
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.